Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 3
2020 157
2021 172
2022 187
2023 189
2024 74

Text availability

Article attribute

Article type

Publication date

Search Results

747 results

Results by year

Filters applied: . Clear all
Page 1
Cancer-associated fibroblasts in the single-cell era.
Lavie D, Ben-Shmuel A, Erez N, Scherz-Shouval R. Lavie D, et al. Nat Cancer. 2022 Jul;3(7):793-807. doi: 10.1038/s43018-022-00411-z. Epub 2022 Jul 26. Nat Cancer. 2022. PMID: 35883004 Free PMC article. Review.
The cGAS-STING pathway and cancer.
Samson N, Ablasser A. Samson N, et al. Nat Cancer. 2022 Dec;3(12):1452-1463. doi: 10.1038/s43018-022-00468-w. Epub 2022 Dec 12. Nat Cancer. 2022. PMID: 36510011 Review.
CD4+ T cells in cancer.
Speiser DE, Chijioke O, Schaeuble K, Münz C. Speiser DE, et al. Nat Cancer. 2023 Mar;4(3):317-329. doi: 10.1038/s43018-023-00521-2. Epub 2023 Mar 9. Nat Cancer. 2023. PMID: 36894637 Review.
Cancer vaccines: the next immunotherapy frontier.
Lin MJ, Svensson-Arvelund J, Lubitz GS, Marabelle A, Melero I, Brown BD, Brody JD. Lin MJ, et al. Nat Cancer. 2022 Aug;3(8):911-926. doi: 10.1038/s43018-022-00418-6. Epub 2022 Aug 23. Nat Cancer. 2022. PMID: 35999309 Review.
Advances in antibody-based therapy in oncology.
Zinn S, Vazquez-Lombardi R, Zimmermann C, Sapra P, Jermutus L, Christ D. Zinn S, et al. Nat Cancer. 2023 Feb;4(2):165-180. doi: 10.1038/s43018-023-00516-z. Epub 2023 Feb 20. Nat Cancer. 2023. PMID: 36806801 Review.
ALK-positive lung cancer: a moving target.
Schneider JL, Lin JJ, Shaw AT. Schneider JL, et al. Nat Cancer. 2023 Mar;4(3):330-343. doi: 10.1038/s43018-023-00515-0. Epub 2023 Feb 16. Nat Cancer. 2023. PMID: 36797503 Free PMC article. Review.
Bystander T cells in cancer immunology and therapy.
Meier SL, Satpathy AT, Wells DK. Meier SL, et al. Nat Cancer. 2022 Feb;3(2):143-155. doi: 10.1038/s43018-022-00335-8. Epub 2022 Feb 28. Nat Cancer. 2022. PMID: 35228747 Review.
Cancer's new normal.
Dolgin E. Dolgin E. Nat Cancer. 2021 Dec;2(12):1248-1250. doi: 10.1038/s43018-021-00304-7. Nat Cancer. 2021. PMID: 35121920 No abstract available.
747 results